Patterns and perceptions of face-to-face and digital communication in the clinical high risk and early stages of psychosis.
Clinical high risk
First episode psychosis
Information technology
Social media
Social support
Journal
Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
06
09
2019
revised:
28
10
2019
accepted:
28
10
2019
pubmed:
11
11
2019
medline:
25
9
2020
entrez:
10
11
2019
Statut:
ppublish
Résumé
Digital communication can mitigate some of the challenges inherent in face-to-face communication; however, it is unclear whether this communication format is preferred among youth with emerging psychosis. Therefore, we examined characteristics of face-to-face and digital communication in youth at clinical high risk for psychosis (CHR; n = 19) or in the first episode of psychosis (FEP; n = 57), as well as age-matched community comparisons (n = 51). Participants completed a 25-item self-report questionnaire to assess between- and within-group differences in the frequency of, satisfaction with, and barriers to face-to-face and digital communication. Compared to controls, both clinical groups endorsed a lower frequency of face-to-face and digital interactions across a range of communication partners. Controls reported higher satisfaction and fewer challenges with both communication formats than CHR and FEP groups. No between-group differences were identified among clinical participants in characteristics of face-to-face and digital interactions. Youth at clinical high risk for, or in the first episode of, psychosis exhibited similar communication patterns and perceptions that significantly diverged from community controls. These findings highlight that reductions in the quality and quantity of social interactions extend to digital contexts, and that both communication formats are relevant clinical targets in the high risk and early stages of psychosis.
Identifiants
pubmed: 31703984
pii: S0165-1781(19)31888-8
doi: 10.1016/j.psychres.2019.112667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112667Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Within the past three years, C.R.B. has served as a consultant for Boehringer Ingelheim, Pfizer, and Lundbeck, and has received grant support from Pfizer, Lundbeck and Takeda. In-Kind Research Support has been provided by Scientific Brain Training, and royalties from Oxford University Press. All other authors report no financial relationships with commercial interests.